• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期严重的ADAMTS - 13缺乏症。

Severe ADAMTS-13 deficiency in childhood.

作者信息

Schneppenheim Reinhard, Budde Ulrich, Hassenpflug Wolf, Obser Tobias

机构信息

Clinic of Paediatric Haematology and Oncology, University Hospital Hamburg-Eppendorf, Germany.

出版信息

Semin Hematol. 2004 Jan;41(1):83-9. doi: 10.1053/j.seminhematol.2003.10.007.

DOI:10.1053/j.seminhematol.2003.10.007
PMID:14727263
Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare microangiopathic disorder with high morbidity and significant mortality. The primary form of TTP is caused by severe deficiency, acquired or hereditary, of the von Willebrand factor cleaving protease (VWF-CP), ADAMTS-13. Because TTP occurs less frequently in children, general pediatricians are not well informed about the spectrum of clinical symptoms and altered laboratory values, increasing the risk of nondiagnosis and possible fatal outcome. If renal involvement is present, the condition can easily be misdiagnosed as hemolytic-uremic syndrome (HUS). We present a case series of children with severe VWF-CP deficiency with emphasis on the clinical heterogeneity responsible for misdiagnosis and inappropriate treatment. The inherited form may involve onset of symptoms ranging from isolated thrombocytopenia to the full clinical picture characteristic of classical TTP. The most common assumed diagnoses of oligosymptomatic forms are immune thrombocytopenia (ITP) and Evans syndrome, respectively. Accordingly, this article is directed towards pediatricians on neonatal and intensive care units, as well as their colleagues specializing in nephrology, hematology, and neurology.

摘要

血栓性血小板减少性紫癜(TTP)是一种罕见的微血管病性疾病,发病率高且死亡率显著。TTP的主要形式是由血管性血友病因子裂解蛋白酶(VWF-CP),即ADAMTS-13严重缺乏引起的,这种缺乏可为获得性或遗传性。由于TTP在儿童中发病率较低,普通儿科医生对其临床症状谱和实验室检查值的改变了解不足,这增加了漏诊风险以及可能的致命后果。如果存在肾脏受累,该病很容易被误诊为溶血尿毒综合征(HUS)。我们呈现了一系列严重VWF-CP缺乏的儿童病例,重点关注导致误诊和不恰当治疗的临床异质性。遗传性形式可能表现出从孤立性血小板减少到典型TTP的完整临床特征等不同症状。寡症状形式最常见的假定诊断分别是免疫性血小板减少症(ITP)和伊文氏综合征。因此,本文面向新生儿和重症监护病房的儿科医生,以及他们在肾病学、血液学和神经学领域的同事。

相似文献

1
Severe ADAMTS-13 deficiency in childhood.儿童期严重的ADAMTS - 13缺乏症。
Semin Hematol. 2004 Jan;41(1):83-9. doi: 10.1053/j.seminhematol.2003.10.007.
2
von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.儿童血栓性血小板减少性紫癜中的血管性血友病因子裂解蛋白酶及ADAMTS13突变
Blood. 2003 Mar 1;101(5):1845-50. doi: 10.1182/blood-2002-08-2399. Epub 2002 Oct 17.
3
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.血栓性血小板减少性紫癜和溶血尿毒综合征的病因及发病机制:血管性血友病因子裂解蛋白酶的作用
Best Pract Res Clin Haematol. 2001 Jun;14(2):437-54. doi: 10.1053/beha.2001.0142.
4
von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.血管性血友病因子、含血小板解聚蛋白基序的金属蛋白酶13与血栓性血小板减少性紫癜
Semin Hematol. 2004 Jan;41(1):4-14. doi: 10.1053/j.seminhematol.2003.10.003.
5
Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的发病机制、诊断及治疗进展
J Am Soc Nephrol. 2003 Apr;14(4):1072-81. doi: 10.1097/01.asn.0000060805.04118.4c.
6
Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜中血管性血友病因子裂解蛋白酶活性缺乏。
Expert Rev Cardiovasc Ther. 2003 Jul;1(2):243-55. doi: 10.1586/14779072.1.2.243.
7
Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).血栓性血小板减少性紫癜/溶血性尿毒症综合征(TTP/HUS)中的两种新型ADAMTS13基因突变。
Kidney Int. 2004 Sep;66(3):955-8. doi: 10.1111/j.1523-1755.2004.00841.x.
8
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.血栓性血小板减少性紫癜和溶血尿毒综合征中的血管性血友病因子裂解蛋白酶
N Engl J Med. 1998 Nov 26;339(22):1578-84. doi: 10.1056/NEJM199811263392202.
9
Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.导致遗传性血栓性血小板减少性紫癜的基因缺陷。
Semin Hematol. 2004 Jan;41(1):34-40. doi: 10.1053/j.seminhematol.2003.10.002.
10
Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.血管性血友病因子裂解蛋白酶缺乏症的常染色体隐性遗传。
Pediatr Nephrol. 2000 Aug;14(8-9):762-5. doi: 10.1007/pl00013432.

引用本文的文献

1
Congenital Thrombotic Thrombocytopenic Purpura With a Novel ADAMTS13 Gene Mutation.伴有新型ADAMTS13基因突变的先天性血栓性血小板减少性紫癜
Cureus. 2020 Dec 13;12(12):e12053. doi: 10.7759/cureus.12053.
2
Thrombotic microangiopathy in haematopoietic cell transplantation: an update.造血细胞移植中的血栓性微血管病:最新进展。
Mediterr J Hematol Infect Dis. 2010;2(3):e2010033. doi: 10.4084/MJHID.2010.033. Epub 2010 Nov 3.
3
Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.儿童严重ADAMTS13缺乏相关的血栓性血小板减少性紫癜
Pediatr Nephrol. 2009 Jan;24(1):19-29. doi: 10.1007/s00467-008-0863-5. Epub 2008 Jun 24.